急性非ST段抬高型心肌梗死患者血清肌钙蛋白T、BNP和炎性因子水平检测的临床意义(2)
第1页 |
参见附件。
[参考文献]
[1] Eggers KM, Lagerqvist B, V enge P1 Prognostic value of biomarkers duringand after non-ST-segment elevation acute coronary synd-rome[J]. Am Coll Cardio, 2009, 54 ( 4 ) : 357- 364.
[2] Rider PM. High- Sensitivity C-reactive protein and cardio lv ascular risk: rationale fo r screening and primary prevention[J]. Am J Cardiol, 2003, 92( suppl) : 17- 22.
[3] Weber M,Bazzino O,Navarro Estrada JL,et al. N-terminal B-type natriuretic peptide assessment provides incrementalprognostic information in patients with acute coronary syndromes and normal troponin T values upon admission[J]. J Am Coll Cardio,2008,51( 12) : 1188-1195.
[4] De Lemos JA,Morrow DA,Blazing MA,et al. Serial measurement of monocyte chemoattractant protein-1 after acutecoronary syndromes: results from the A to Z trial[J]. Am J Cardiol,2007,50( 27) : 2117-2124.
[5] Mayer O Jr, Simon J, Plskov M. N-terminal pro B- type natriu retic peptide as prognostic marker for mortality in coron ary patients with out clinically manifest heart failure[J]. Eur Epidemio, 2009, 24 (7):363-368.
[6] 任晓华, 崔文丽 .不同剂量阿托伐他汀对急性冠脉综合征患者超敏C 反应蛋白的影响[J]. 河北医药, 2008, 30(9):13501.
[7] 郑兵. 肌钙蛋白T与超敏C 反应蛋白联合检测在急性冠脉综合征中的临床意义[J]. 国际检验医学杂志,2010,31(9):1041-1042.
[8] 李亚. 血浆B型钠尿肽在急性非ST段抬高型冠脉综合征预后预测的临床应用及与炎症因子的相关性研究[J]. 中国全科医学, 2010,13(11A):3523-3525.
(收稿日期:2012-11-08)
您现在查看是摘要介绍页,详见PDF附件(1897kb)。